APTOKYO: Japan's Nikkei index closed higher on Thursday, as shipping firms rose on prospects of more economic reopenings and drugmakers were boosted by reports of government support.
The Nikkei share average ended 0.34 per cent higher at 28,958.56, while the broader Topix ticked down 0.02 per cent to 1,956.73.
Signs that more economies are reopening amid a steady vaccine rollout underpinned shipping firms, with Nippon Yusen jumping 3.65 per cent to be the biggest gainer on the Nikkei.
Japan plans to finish vaccinating all citizens who have applied for shots by October-November, Prime Minister Yoshihide Suga said during a debate between party leaders on Wednesday.
Eisai sank 7.02 per cent after two days of gains by daily limit. U.S. regulators earlier this week approved a drug developed by the firm and for Alzheimer's disease. For the week, the stock has gained 30 per cent so far.
Rival drugmaker Shionogi rose 3.4 per cent on a local media report that the firm plans to mass-produce its own Covid-19 vaccines.
Chugai Pharmaceutical gained 1.04 per cent and Ono Pharmaceutical rose 1.5 per cent on a media report they will receive government subsidies for their research on Covid-19 drugs.
The TSE's air transport index hit a 15-month high before slipping 0.49 per cent as investors locked in profits.
"Some people say their rally on economic reopenings would last only about two weeks. In the past year, that has been the case because we were able to contain the Covid-19 only temporarily," said Fumio Matsumoto, chief strategist at Okasan Securities.
"But this time, with vaccines, I think their rally could last much longer albeit with twists and turns."
Meanwhile, DIY shop operator Konan Shoji jumped 20 per cent after City Index Eleventh, a Japanese fund backed by veteran activist investor Yoshiaki Murakami, disclosed that it owns more than 5 per cent of the firm's shares.
The Nikkei share average ended 0.34 per cent higher at 28,958.56, while the broader Topix ticked down 0.02 per cent to 1,956.73.
Signs that more economies are reopening amid a steady vaccine rollout underpinned shipping firms, with Nippon Yusen jumping 3.65 per cent to be the biggest gainer on the Nikkei.
Did you Know?
Stock score of Biogen Pharmachem Industries Ltd moved down by 1 in a month.
View Latest Stock Report »Japan plans to finish vaccinating all citizens who have applied for shots by October-November, Prime Minister Yoshihide Suga said during a debate between party leaders on Wednesday.
Eisai sank 7.02 per cent after two days of gains by daily limit. U.S. regulators earlier this week approved a drug developed by the firm and for Alzheimer's disease. For the week, the stock has gained 30 per cent so far.
Rival drugmaker Shionogi rose 3.4 per cent on a local media report that the firm plans to mass-produce its own Covid-19 vaccines.
Chugai Pharmaceutical gained 1.04 per cent and Ono Pharmaceutical rose 1.5 per cent on a media report they will receive government subsidies for their research on Covid-19 drugs.
The TSE's air transport index hit a 15-month high before slipping 0.49 per cent as investors locked in profits.
"Some people say their rally on economic reopenings would last only about two weeks. In the past year, that has been the case because we were able to contain the Covid-19 only temporarily," said Fumio Matsumoto, chief strategist at Okasan Securities.
"But this time, with vaccines, I think their rally could last much longer albeit with twists and turns."
Meanwhile, DIY shop operator Konan Shoji jumped 20 per cent after City Index Eleventh, a Japanese fund backed by veteran activist investor Yoshiaki Murakami, disclosed that it owns more than 5 per cent of the firm's shares.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.